Abstract:Background: Excessive endogenous glucose production is a major contributing factor for fasting hyperglycemia in diabetes. Results: FoxO6 deficiency attenuates hepatic gluconeogenesis and protects against fat-induced glucose disorder in mice. Conclusion: FoxO6 plays a significant role in regulating gluconeogenesis in the liver. Significance: FoxO6 is a potential therapeutic target for improving glucose metabolism in diabetes. Excessive endogenous glucose production contributes to fasting hyperglycemia in diabetes. FoxO6 is a distinct member of the FoxO subfamily. To elucidate the role of FoxO6 in hepatic gluconeogenesis and assess its contribution to the pathogenesis of fasting hyperglycemia in diabetes, we generated FoxO6 knock-out (FoxO6-KO) mice followed by determining the effect of FoxO6 loss-of-function on hepatic gluconeogenesis under physiological and pathological conditions. FoxO6 depletion attenuated hepatic gluconeogenesis and lowered fasting glycemia in FoxO6-KO mice. FoxO6-deficient primary hepatocytes were associated with reduced capacities to produce glucose in response to glucagon. When fed a high fat diet, FoxO6-KO mice exhibited significantly enhanced glucose tolerance and reduced blood glucose levels accompanied by improved insulin sensitivity. These effects correlated with attenuated hepatic gluconeogenesis in FoxO6-KO mice. In contrast, wild-type littermates developed fat-induced glucose intolerance with a concomitant induction of fasting hyperinsulinemia and hyperglycemia. Furthermore, FoxO6-KO mice displayed significantly diminished macrophage infiltration into liver and adipose tissues, correlating with the reduction of macrophage expression of C-C chemokine receptor 2 (CCR2), a factor that is critical for regulating macrophage recruitment in peripheral tissues. Our data indicate that FoxO6 depletion protected against diet-induced glucose intolerance and insulin resistance by attenuating hepatic gluconeogenesis and curbing macrophage infiltration in liver and adipose tissues in mice.

Differential roles of FOXO transcription factors on insulin action in brown and white adipose tissue

On the role of FOX transcription factors in adipocyte differentiation and insulin-stimulated glucose uptake

FoxO1 Plays an Important Role in Regulating Β-Cell Compensation for Insulin Resistance in Male Mice.

Aberrant Forkhead Box O1 Function is Associated with Impaired Hepatic Metabolism

FOXO1 involvement in insulin resistance-related pro-inflammatory cytokine production in hepatocytes

Regulation of FoxOs Transcription Factors on Body Metabolism

A Mutant Allele Encoding DNA Binding–Deficient FoxO1 Differentially Regulates Hepatic Glucose and Lipid Metabolism

Foxo1 Mediates Insulin Action on Apoc-Iii and Triglyceride Metabolism

FoxO integration of insulin signaling with glucose and lipid metabolism.

FoxO1 Links Hepatic Insulin Action to Endoplasmic Reticulum Stress

FoxO1 suppresses Fgf21 during hepatic insulin resistance to impair peripheral glucose utilization and acute cold tolerance

FoxO1 at the nexus between fat catabolism and longevity pathways

Male Brown Fat–Specific Double Knockout of IGFIR/IR: Atrophy, Mitochondrial Fission Failure, Impaired Thermogenesis, and Obesity

FoxO6 Integrates Insulin Signaling with Gluconeogenesis in the Liver.

Foxp1 controls brown/beige adipocyte differentiation and thermogenesis through regulating β3-AR desensitization

Inhibitory regulation of FoxO1 in PPARδ expression drives mitochondria dysfunction and insulin resistance

Tissue-Specific Metabolic Regulation of FOXO-Binding Protein: FOXO Does Not Act Alone

Molecular Mechanisms of FOXO1 in Adipocyte Differentiation

Forkhead Box O6 (foxo6) Depletion Attenuates Hepatic Gluconeogenesis and Protects Against Fat-induced Glucose Disorder in Mice.

FoxO6 in glucose metabolism (FoxO6).

The forkhead box transcription factor FoxP4 regulates thermogenic programs in adipocytes